USPTO serial 79134109
REXULTI VORTIOXETINE
Reviewed by CopyMark Law Group
Reg. 4582247Status 404
- Filing date
- Status date
- Registration date
- Aug 12, 2014
- Examiner
- KIDWELL WALKER, JACLYN NOEMI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with REXULTI VORTIOXETINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Claudia A. Smith
Claudia A. Smith White & Case LLP1155 Avenue of the AmericasPatent and Trademark DepartmentNew York, NY 10036Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression, psychosis, anxiety, insomnia, schizophrenia, bipolar disorder and disease, pain, alcoholism and addiction; preparations, substances, reagents and agents for diagnostic and medical purposes; all the forgoing containing in whole or substantial part vortioxetine | SECTION 70 - CANCELLED | — |
| 009 | Scientific apparatus and instruments, namely, magnetic, electronic and optical data carriers containing information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and treatment and prevention of diseases and disorders; pre-recorded audio cassettes, pre-recorded video cassettes, and electronic and digital media featuring information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and treatment and prevention of diseases and disorders; downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders; recorded computer software, namely, software for searching, storing, cataloging, and indexing medical and pharmaceutical information, indexing education and sales activities and for enabling web-based access to websites, enabling database integration, and enabling web searching of websites, intranet and Internet; data processing equipment and computers; software, namely, downloadable application software containing information on the use of pharmaceutical products and on diseases and disorders of the central nervous system and the treatment thereof; downloadable electronic game software which provide information related to diseases and disorders of the central nervous system and the treatment thereof, and downloadable mobile application software that allows transmitting, sharing, receiving, downloading, displaying and transferring content, text, visual works, audio works, audiovisual works, literary works, data, files, documents and electronic works via portable and handheld electronic devices and computers in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and treatment and prevention of diseases and disorders; application software for mobile devices, apparatus and medical instruments for controlling and managing patient medical information and interaction | SECTION 70 - CANCELLED | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments, namely, examination systems consisting primarily of medical instruments for use in diagnosing central nervous system disorders; suture materials; apparatus and instruments for diagnostic purposes for diseases and disorders of the central nervous system; integrated medical systems consisting primarily of medical instruments for central nervous system and central nervous system related diagnostics, computer hardware and software for medical information and medical information management for use of a web-based physical and psychological examination and assessment of patients and information, guidance and control of medicines | SECTION 70 - CANCELLED | — |
| 041 | Education, namely, providing seminars, conferences, symposiums, workshops, courses, classes and lectures in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; providing of training in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; entertainment, namely, organizing, arranging, and conducting running, walking, golf, tennis, softball, and cycling events and cultural activities; arranging and conducting seminars, conferences, symposiums, workshops, and training courses in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; educational and training services in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders; educational and training services in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders all provided electronically, on-line, via cable and Internet and other electronic media; providing nondownloadable on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders | SECTION 70 - CANCELLED | — |
| 042 | Scientific and technological services in the nature of scientific research, analysis, and testing and research and design relating thereto in the field of medicine; industrial research and analysis of diseases and disorders, treatments of diseases and disorders and prevention of diseases and disorders; design and development of computer hardware and software; providing software and access to data and information in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; pharmaceutical research and development; scientific and technological services in the nature of scientific research, analysis, and testing in the field of disorders, diseases and prevention; scientific and technological services in the nature of scientific research, analysis, and testing in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and tests; clinical research and tests; diagnostic research and tests; providing for medical and medicinal information related to medical diagnostics, medicine, pharmaceuticals, diseases, disorders, treatments of diseases and disorders, and prevention of diseases and disorders in the field of research and development, science, clinical tests | SECTION 70 - CANCELLED | — |
| 044 | Medical services; services in the field of psychiatry and psychology; services and advice related to medical and pharmaceutical preparations and substances; medical clinical services; medical treatment services; therapeutic medical treatment services; healthcare and medical services related to central nervous system disorders, diseases and pharmaceuticals; providing for medical and medicinal information in the field of diagnostic medicine, medical dose, pharmaceuticals, disorders, diseases, treatments and prevention; all the aforementioned services provided off-line as well as on-line through a website featuring advice and information on the foregoing | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named REXULTI VORTIOXETINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2015 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jul 31, 2015 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 13, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 27, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 27, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 12, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 12, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 12, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 27, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 27, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 23, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 7, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 7, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 7, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 17, 2014 | DMCC | DATA MODIFICATION COMPLETED | — |
| Apr 17, 2014 | PBPR | WITHDRAWN FROM PUB - ESU SUPERVISOR REQUEST | — |
| Apr 16, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 16, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 16, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 16, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 16, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 16, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 8, 2014 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 5, 2014 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 27, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 24, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 24, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 24, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 24, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 24, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 4, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 4, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2014 | ALIE | ASSIGNED TO LIE | — |
| Feb 19, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 4, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 4, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 31, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 30, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 20, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 20, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 16, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 15, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |